IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 407 
Small font sizeDefault font sizeIncrease font size
Navigate Here
 »   Next article
 »   Previous article
 »   Table of Contents

Resource Links
 »   Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
 »   Citation Manager
 »   Access Statistics
 »   Reader Comments
 »   Email Alert *
 »   Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1116    
    Printed62    
    Emailed0    
    PDF Downloaded77    
    Comments [Add]    

Recommend this journal

 

 SHORT COMMUNICATION
Year : 1975  |  Volume : 7  |  Issue : 4  |  Page : 27-30

A double blind clinical study of prenylamine lactate in the cases of ischaemic heart disease



Correspondence Address:
K C Kotia


Login to access the Email id

Source of Support: None, Conflict of Interest: None


Rights and PermissionsRights and Permissions

In the present double-blind trial, 25 cares received prenylamine and 26 cases placebo. The patients were observed for 6 weeks before institution of therapy and for another 6 weeks during therapy. Clinical as well as electrocardiographic assessment was done. There was improvement in frequency and severity of anginal attacks and the consumption of GTN tablets in both groups decreased. But this improvement was highly significant in prenylamine serieses compared to placebo. Electrocardiographic improvement was also more marked with prenylamine than with placebo. The side effects were even less marked in prenylamine series. Hence it is concluded that patients of angina pectoris are more benefitted with prenylamine than with placebo.






[PDF]*


        
Print this article     Email this article

Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer
Online since 20th July '04
Published by Wolters Kluwer - Medknow